Our Resources

The upgraded platform gives sponsors the ability to mix hybrid and virtual trial designs within one study, easily tailoring workflows to sites, locations, and study populations.

The FDA and OHRP have released new draft guidance providing recommendations for making the informed consent process as clear and comprehensive as possible for participants. Here's what you need to know.

ObvioHealth’s innovative study design will allow Ready. Set. Food! to follow babies in the real world for two years.

In this webinar, our expert panelists—including a participant—explore the Mi-Helper clinical trial as a case study, reviewing the challenges associated with conducting medical device studies remotely, and how collaboration and iteration can help to identify and mitigate risks from the outset. Download the webinar summary by filling out the form below.

Patient-reported outcomes are crucial components of every clinical trial—and they’re stronger and more accurate when captured electronically. Here’s what you need to know about PROs and ePROs.

A government agency is aiming to identify digital biomarkers of depressive and anxious feelings. The agency needed to capture both objective and subjective data for analysis.

A biopharmaceutical company is seeking a Phase IV clinical trial to confirm the safety and efficacy of its ADHD therapeutic on a more real-world population. Phases I-III included narrow inclusion and exclusion criteria.

Medical device company, Mi-Helper, Inc., needed to find participants with a specific type of migraine. This required a long run-in period and mitigation to reduce the risk of drop-off before participants reached active treatment. In addition, Mi-Helper needed to ensure participants used the at-home device properly.